| Literature DB >> 22607047 |
Yanhong Li1, Jian Wang, Xueming Zhu, Qihua Feng, Xiaozhong Li, Xing Feng.
Abstract
BACKGROUND: Several renal histopathological features, including mesangial hypercellularity, glomerulosclerosis, tubular atrophy and interstitial fibrosis, are considered to be independent predictors of end-stage renal failure in patients with glomerular diseases. Mesangial proliferative glomerulonephritis (MesPGN) is characterized by proliferations of mesangial cells with increase in mesangial matrix and/or deposits in mesangial region. The purpose of this study is to determine the association between urinary protein markers measured at the same time as renal biopsy and the severity of renal histological lesions in children with MesPGN, and to evaluate whether these markers could serve as predictors of severe renal histological lesions in this population.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22607047 PMCID: PMC3403987 DOI: 10.1186/1471-2369-13-29
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Patient characteristic at the time of renal biopsy
| Characteristics | IgAN | IgMN | MesPGN | ||
|---|---|---|---|---|---|
| Age, years | | 10.2 [3.9‒15] | 9.4 [3.9‒13.6] | 6.2 [2.8‒13.2] | .002 |
| Sex, male/ female | | 28/12 | 20/17 | 10/11 | NS |
| Body weight, kg | | 33.5 [15.5‒71] | 27 [14‒62.5] | 20 [14‒65] | .015 |
| Duration of disease prior to biopsy, months | | 2 [0.23‒120] | 12 [0.33‒84] | 6 [0.67‒48] | .012 |
| Hematuria, n (%) | | 39 (98) | 36 (97) | 21 (100) | NS |
| Macro hematuria, n (%) | | 25 (63) | 7 (19) | 4 (19) | .000 |
| Proteinuria > 4mg/m2/h, n (%) | | 27 (68) | 18 (49) | 11 (52) | NS |
| Proteinuria > 40mg/m2/h, n (%) | | 16 (40) | 8 (22) | 4 (19) | NS |
| Serum creatinine > 1.5mg/dl, n (%) | | 1 (3) | 0 (0) | 0 (0) | NS |
| Hypertensiona, n (%) | | 4 (10) | 2 (5) | 2 (10) | NS |
| Clinical features, n (%) | Isolated hematuria | 13 (33) | 19 (51) | 10(48) | NS |
| | Proteinuria with or without hematuria | 18 (45) | 10 (27) | 6 (29) | NS |
| | Nephritic syndromeb | 2 (5) | 1 (3) | 0 (0) | NS |
| | Nephrotic syndromec | 6 (15) | 7 (19) | 5 (24) | NS |
| | Acute kidney injuryd | 1 (3) | 0 (0) | 0 (0) | NS |
| Histological features, n (%) | Adhesion | 12 (30) | 8 (22) | 8 (38) | NS |
| Sclerosis | 5 (13) | 0 (0) | 1 (5) | NS | |
| Crescent | 1 (3) | 0 (0) | 0 (0) | NS | |
| Endocapillary hypercellularity | 8 (20) | 2 (5) | 3 (14) | NS | |
| Tubular atrophy | 9 (23) | 5 (14) | 4 (19) | NS | |
| Interstitial fibrosis | 2 (5) | 2 (5) | 1 (5) | NS | |
| Interstitial inflammation | 6 (15) | 4 (11) | 2 (10) | NS | |
| Arteriolar lesions | 0 (0) | 0 (0) | 0 (0) | NS | |
| Severe MC (score ≥ 2)e | 20 (50) | 9 (24) | 5 (24) | .030 | |
| Severe GS (score ≥ 2)f | 9 (23) | 5 (14) | 3 (14) | NS | |
| Severe TID (score ≥ 2)g | 11 (28) | 5 (14) | 4 (19) | NS | |
| Severe MC + severe GS | 6 (15) | 2 (5) | 2 (10) | NS | |
| Severe MC + severe TID | 6 (15) | 2 (5) | 2 (10) | NS | |
| Severe GS + severe TID | 5 (13) | 3 (8) | 0 (0) | NS | |
| Severe MC + GS + TID | 3 (8) | 1 (3) | 0 (0) | NS | |
| Treatmen, n (%) | Prednisone | 18 (45) | 14 (38) | 7 (33) | NS |
| Cyclophosphamide | 4 (10) | 3 (8) | 3 (14) | NS |
Values are median [range]; NS, not significant; GS, Glomerulosclerosis; MC, mesangial cellularity; TID, tubule‒interstitial damage aHypertension, defined as diastolic and/or systolic pressure higher than the 95th percentile for age, sex, and height percentile. bNephritic syndrome, defined as hematuria, red blood cell casts, proteinuria, and/or renal insufficiency, and/or hypertension. cNephrotic syndrome, defined as 24‒h proteinuria > 40mg/m2/h and serum albumin level < 2.5 g/dl. dAcute kidney injury, defined as a ≥ 50% decrease in estimated creatinine clearance, based on Schwartz formula. eSevere MC (score ≥ 2), defined as > 5 mesangial cells/ mesangial area. fSevere GS (score ≥ 2), defined as ≥ 10% glomeruli showing segmental adhesions or sclerosis. gSevere TID (score ≥ 2), defined as focal or diffuse tubular and interstitial lesions
Comparison of urinary proteins among children with IgAN, IgMN and MesPGN without IgA/IgM
| Urinary protein markers | IgAN n = 40 | IgMN n = 37 | MesPGN without IgA/IgM n = 21 | |
|---|---|---|---|---|
| u IgG (mg/g uCr) | 65.2 [2.6‒926.7] | 6.5 [0.2‒397.1] | 9.8 [1.6‒842.4] | NS |
| u Albumin (mg/g uCr) | 372.8 [8–2937] | 24.6 [4–1764] | 53.4 [6–3300] | .021 |
| u Transferrin (mg/g uCr) | 63.7 [0.5‒441.7] | 2.5 [0.4‒804.1] | 4.8 [0.3‒936.2] | NS |
| u α1‒microglobulin (mg/g uCr) | 9.5 [0.1‒234.9] | 5.0 [1.1‒104.5] | 5.5 [0.7‒84.9] | NS |
| u β2‒microglobulin (mg/g uCr) | 0.4 [0.1‒3.0] | 0.4 [0.1‒1.4] | 0.4 [0.0‒4.1] | NS |
| u NAG (u/g uCr) | 17.8 [4.5‒172.0] | 7.6 [2.1‒47.8] | 11.8 [1.8‒48.6] | NS |
| 24‒h Proteinuria (mg/m2/h) | 37.0 [2.0‒257.0] | 4.4 [0.5‒335.0] | 37.2 [4.1‒197.3] | NS |
Values are median [range]; NAG: N‒acetyl‒β‒glucosaminidase; NS, not significant
*The difference did not remain significant after adjustment for age using ANCOVA analysis. The level of urinary proteins was log‒transformed for ANCOVA analysis
Comparison of clinical and laboratory parameters between children with mild and severe renal histological lesions
| | Mesangial cellularity | Glomerulosclerosis | Tubule‒interstitial damage | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mild | Severe | Mild | Severe | Mild | Severe | |||||
| Number of patients | 64 | 34 | | 81 | 17 | | 78 | 20 | | |
| Age, years | 9.5 [2.8‒15] | 9.8 [3.9‒15] | NS | 9.1 [2.8‒15] | 10.4 [4.1‒14.3] | NS | 8.5 [2.8‒15] | 11.7 [3.1‒15] | .001 | |
| Sex (male/ female) | 36/28 | 22/12 | NS | 48/33 | 10/7 | NS | 43/35 | 15/5 | NS | |
| Body weight, kg | 30 [14‒71] | 31.5 [15‒65] | NS | 27.5 [14‒71 | 32 [15.5‒57] | NS | 27 [14‒65] | 37 [17‒71] | .003 | |
| Histological diagnosis, n (%) | ||||||||||
| IgAN | 20 (31) | 20 (59) | .008 | 31 (38) | 9 (53) | NS | 29 (37) | 11 (55) | NS | |
| IgMN | 28 (44) | 9 (26) | NS | 32 (40) | 5 (29) | NS | 32 (41) | 5 (25) | NS | |
| MesPGN(IgA‒ IgM‒) | 16 (25) | 5 (15) | NS | 18 (22) | 3 (18) | NS | 17 (22) | 4 (20) | NS | |
| Clinical features* n (%) | ||||||||||
| Mild | 55 (86) | 21 (62) | .006 | 65 (80) | 11 (65) | NS | 61 (78) | 15 (75) | NS | |
| Severe | 9 (14) | 13 (38) | .006 | 16 (20) | 6 (35) | NS | 17 (22) | 5 (25) | NS | |
| Hematuria n (%) | ||||||||||
| 5‒10RBC/HPF | 11 (17) | 2 (6) | NS | 12 (15) | 1 (6) | NS | 10 (13) | 3 (15) | NS | |
| 10‒30RBC/HPF | 36 (56) | 23 (68) | NS | 47 (58) | 12 (71) | NS | 43 (55) | 16 (80) | NS | |
| > 30RBC/HPF | 16 (25) | 8 (24) | NS | 21 (26) | 3 (18) | NS | 23 (29) | 1 (5) | .021 | |
| Proteinuria, n (%) | ||||||||||
| > 4mg/m2/h | 29 (45) | 27 (79) | .001 | 42 (52) | 14 (82) | .021 | 44 (56) | 12 (60) | NS | |
| > 40mg/m2/h | 11 (17) | 17 (50) | .001 | 18 (22) | 10 (59) | .002 | 19 (24) | 9 (45) | NS | |
| Prednisone, n (%) | 18 (28) | 21 (62) | .001 | 27 (33) | 12 (71) | .004 | 28 (36) | 11 (55) | NS | |
| Cyclophosphamide | 4 (6) | 6 (18) | NS | 5 (6) | 5 (29) | .013 | 6 (8) | 4 (20) | NS | |
Values are median [range]; NS, not significant.
Mild mesangial cellularity is defined as 4–5 mesangial cells on per mesangial area (score < 2); severe is defined as > 5 mesangial cells on per mesangial area (score ≥ 2).
Mild glomerulosclerosis is defined as absent or less than 10 % of all biopsied glomeruli showing segmental adhesions or sclerosis (score < 2); severe is defined as ≥ 10 % glomeruli showing segmental adhesions or sclerosis (score ≥ 2).
Mild tubule‒interstitial damage is defined as tubular and interstitial lesions absent or very mildly focal (score < 2); severe is defined as focal or diffuse tubular and interstitial lesions (score ≥ 2).
*Clinical features: the patients were classified into five categories according to their renal manifestations at the time of biopsy: (1) micro‒ or macroscopic hematuria; (2) asymptomatic proteinuria with or without hematuria; (3) acute nephritic syndrome; (4) nephrotic syndrome; (5) Acute kidney injury. Classes 1 and 2 were considered as mild clinical features, and classes 3–5 as severe.
Figure 1Comparison of urinary protein markers between children with mild and severe renal histological lesions. Comparison of urinary proteins between children with severe mesangial cellularity (MC) defined as > 5 mesangial cells/ mesangial area (score ≥ 2, n = 34) and those with mild MC (score < 2, n = 64); between children with severe glomerulosclerosis (GS) defined as ≥ 10 % glomeruli showing segmental adhesions or sclerosis (score ≥ 2, n = 17) and those with mild GS (score < 2, n = 81); and between children with severe tubule-interstitial damage (TID) defined as focal or diffuse tubular and interstitial lesions (score ≥ 2, n = 20) and those with mild TID (score < 2, n = 78). Urinary excretion of IgG (A), albumin (B), transferrin (C), NAG (D), α1-microglobulin (E) and β2-microglobulin (F) was log transformed. Values are medians, boxes represent interquartile range, whiskers indicate smallest and largest non-outlier observation, and circles indicate outliers. Probability values: two-sample Kolmogorov-Smirnov test, *p < 0.05.
Association ofurinary proteinswith renalhistological lesions
| Odds ratio | 95 % CI | ||
|---|---|---|---|
| | | | |
| u IgG (mg/g uCr) | 2.86 | 1.36‒6.03 | .006 |
| u Albumin (mg/g uCr) | 3.57 | 1.80‒7.07 | .000 |
| u Transferrin (mg/g uCr) | 2.90 | 1.64‒5.12 | .000 |
| u α1‒microglobulin (mg/g uCr) | 2.85 | 1.13‒7.21 | .027 |
| 24‒h Proteinuria (mg/m2/h) | 2.79 | 1.15‒6.81 | .024 |
| | | | |
| u Transferrin (mg/g uCr) | 1.86 | 1.03‒3.36 | .038 |
| 24‒h Proteinuria (mg/m2/h) | 5.16 | 1.37‒19.43 | .015 |
| | | | |
| u Transferrin (mg/g uCr) | 1.89 | 1.01‒3.54 | .048 |
| u NAG (mg/g uCr) | 45.39 | 2.10‒980 | .015 |
The level of urinary proteins was log‒transformed due to a skewed distribution
Odds ratio represents the increase in odds per log increase in the level of urinary proteins.
* The association remained significant after adjustment for potential confounders, including age, clinical features, histological diagnosis or treatment with prednisone and cyclophosphamide.
Predictive characteristics of urinary proteins for severe renal histological lesions
| AUC | 95% CI | Optimal cut‒off value | Sensitivity (%) | Specificity (%) | |||
|---|---|---|---|---|---|---|---|
| u Transferrin | 0.86 | 0.74‒0.99 | .000 | 45 mg/g uCr | 88 | 74 | |
| u Albumin | 0.79 | 0.64‒0.95 | .003 | 372 mg/g uCr | 82 | 74 | |
| u α1‒microglobulin | 0.78 | 0.62‒0.94 | .005 | 22 mg/g uCr | 82 | 74 | |
| u IgG | 0.77 | 0.61‒0.92 | .006 | 65 mg/g uCr | 77 | 74 | |
| 24‒h Proteinuria | 0.78 | 0.63‒0.93 | .004 | 32 mg/m2/h | 77 | 68 | |
| u Transferrin | 0.82 | 0.68‒0.95 | .007 | 136 mg/g uCr | 100 | 74 | |
| 24‒h Proteinuria | 0.79 | 0.64‒0.93 | .014 | 40 mg/m2/h | 88 | 61 | |
| u NAG | 0.82 | 0.69‒0.94 | .004 | 25 u/g uCr | 75 | 77 | |
| u Transferrin | 0.74 | 0.54‒0.94 | .030 | 97 mg/g uCr | 75 | 77 | |
AUC, area under the receiver‒operating‒characteristic curve; CI, confidence interval.
Severe mesangial cellularity, defined as > 5 mesangial cells on per mesangial area.
Severe glomerulosclerosis, defined as ≥ 10 % glomeruli showing segmental adhesions or sclerosis.
Severe tubule‒interstitial damage, defined as focal or diffuse tubular and interstitial lesions.